nir178 Search Results


92
MedChemExpress i927000 nir178 taminadenant medchem express
I927000 Nir178 Taminadenant Medchem Express, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/i927000 nir178 taminadenant medchem express/product/MedChemExpress
Average 92 stars, based on 1 article reviews
i927000 nir178 taminadenant medchem express - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

90
Novartis nir178
Summary of major marketed and clinically reported small molecule immunotherapy drugs (Up to March 2022).
Nir178, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nir178/product/Novartis
Average 90 stars, based on 1 article reviews
nir178 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Surface Oncology nir178
Current development status of Adenosine Receptor Antagonists in advanced non-small cell lung cancer.
Nir178, supplied by Surface Oncology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nir178/product/Surface Oncology
Average 90 stars, based on 1 article reviews
nir178 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Corvus Pharmaceuticals nir 178
Current development status of Adenosine Receptor Antagonists in advanced non-small cell lung cancer.
Nir 178, supplied by Corvus Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nir 178/product/Corvus Pharmaceuticals
Average 90 stars, based on 1 article reviews
nir 178 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Summary of major marketed and clinically reported small molecule immunotherapy drugs (Up to March 2022).

Journal: Frontiers in Immunology

Article Title: Clinical cancer immunotherapy: Current progress and prospects

doi: 10.3389/fimmu.2022.961805

Figure Lengend Snippet: Summary of major marketed and clinically reported small molecule immunotherapy drugs (Up to March 2022).

Article Snippet: A2AR , NIR178 , , Novartis , Phase II (NCT03207867).

Techniques:

Current development status of Adenosine Receptor Antagonists in advanced non-small cell lung cancer.

Journal: Frontiers in Immunology

Article Title: Targeting Immunometabolism Mediated by CD73 Pathway in EGFR -Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance

doi: 10.3389/fimmu.2020.01479

Figure Lengend Snippet: Current development status of Adenosine Receptor Antagonists in advanced non-small cell lung cancer.

Article Snippet: NCT03549000 , NIR178 , A2AR antagonist , Surface oncology, novartis , I , NSCLC; TNBC; PDAC; Colorectal Cancer MSS; Ovarian Cancer; RCC; mCRPC , NIR178; NZV930; Spartalizumab.

Techniques:

Current development status of anti-CD73 strategies in advanced non-small cell lung cancer.

Journal: Frontiers in Immunology

Article Title: Targeting Immunometabolism Mediated by CD73 Pathway in EGFR -Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune Resistance

doi: 10.3389/fimmu.2020.01479

Figure Lengend Snippet: Current development status of anti-CD73 strategies in advanced non-small cell lung cancer.

Article Snippet: NCT03549000 , NIR178 , A2AR antagonist , Surface oncology, novartis , I , NSCLC; TNBC; PDAC; Colorectal Cancer MSS; Ovarian Cancer; RCC; mCRPC , NIR178; NZV930; Spartalizumab.

Techniques: